Inov8 Science, based in Wolverton, Milton Keynes in the UK, has developed a technology that reduces the spread of airborne infections ranging from MRSA and C.Difficile to the H1N1 virus that causes swine flu. Based on a concept originally developed at the UK Government Research Facility at Porton Down, and called the Open Air Factor, the INOV8 Air Disinfection (AD) units are able to treat indoor air spaces in offices, factories, surgeries, hospitals, and indeed any space in which people meet. Each AD treats air space of approximately 10m x 10m x 3m.
Inov8’s chief technology officer, Dr Ian Widger says the AD units can provide “significant protection” against almost all strains of the influenza virus.
“We have recently completed both laboratory and field trials that have demonstrated incredibly high levels of airborne pathogen kill, so it is very encouraging that the effectiveness of the AD system has been proven in time to give people confidence in the technology,” he says. “As a result, they will be able to protect themselves, staff, visitors, patients and customers from airborne infections.”
Inov8 Science is ramping up production of the AD units in advance of the second swine flu wave which will enable organisations to take action now, in order to limit the effects of the disease. Contact Adrian Gee-Turner .(JavaScript must be enabled to view this email address) www.inov8science.com
